Home›Stock Screener›Concord Biotech›P/E Ratio

Concord Biotech P/E Ratio

Current P/E Ratio
58.03
High Valuation
Very High - High growth expectations or significantly overvalued

Concord Biotech (CONCORDBIO) P/E ratio is 58.03 (High), EPS (TTM) ₹24.78, current price ₹1548.00 on NSE vs historical average P/E of 50.69 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Compare with CONCORDBIO fundamental valuation to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/E Ratio 58.03
Current Price ₹1548.00
EPS (TTM) ₹24.78
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 50.69
Historical Range 32.39 - 72.25
Percentile 66.7%

Sector Context

Sector Average 54.4
Sector Median 30.97
Sector Rank #11 of 198
Sector Percentile 5.6%

Earnings Breakdown (TTM)

TTM EPS ₹33.43
Mar 2026 ₹8.46
Jun 2026 ₹5.52

CONCORDBIO P/E Ratio — Valuation Signal & Historical Context

Concord Biotech P/E 58.03 vs historical average 50.69, range 32.39–72.25 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Concord Biotech share price chart.

  • Stock appears overvalued with PE of 58.03, suggesting caution for new investments

Concord Biotech P/E Ratio Historical Trend

CONCORDBIO annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 58.03 vs historical average 50.69. View CONCORDBIO price range for the annual high/low range and current price position.

CONCORDBIO Historical P/E Ratio — EPS, Year-End Price & Valuation

Concord Biotech annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 72.25 29.74 ₹2148.75 NSE High
2024 47.43 31.19 ₹1479.40 NSE High
2023 32.39 29.11 ₹942.80 NSE High

CONCORDBIO vs Healthcare Peers — P/E Ratio Comparison

Concord Biotech P/E 58.03 vs Healthcare average 54.4, median 30.97 — range 2.86–700.0.

Sector Average
54.4
Sector Median
30.97
Lowest P/E
2.86
Highest P/E
700.0
Companies
198
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 2.98 ₹52 Low
Colinz Laboratories COLINZ 3.34 ₹10 Low
Sun Pharma Advanced Rese… SPARC 4.03 ₹6,329 Low
Sunrest Lifescience SUNREST 4.19 ₹67 Low
GKB Ophthalmics GKB 5.81 ₹32 Low
JFL Life Sciences JFLLIFE 5.83 ₹78 Low
Dipna Pharmachem DPL 5.9 ₹14 Low
Shelter Pharma SHELTER 6.3 ₹57 Low
Royal Sense ROYAL 6.73 ₹48 Low